NGM Annual Shareholders Equity
$148.64 M
-$110.92 M-42.73%
31 December 2023
Summary:
As of January 31, 2025, NGM annual stockholders equity is $148.64 million, with the most recent change of -$110.92 million (-42.73%) on December 31, 2023. During the last 3 years, it has fallen by -$131.41 million (-46.92%).NGM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Quarterly Shareholders Equity
$148.64 M
-$21.17 M-12.47%
31 December 2023
Summary:
As of January 31, 2025, NGM quarterly stockholders equity is $148.64 million, with the most recent change of -$21.17 million (-12.47%) on December 31, 2023. Over the past year, it has dropped by -$72.30 million (-32.72%).NGM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.7% | -32.7% |
| 3 y3 years | -46.9% | -46.9% |
| 5 y5 years | +237.4% | +237.4% |
NGM Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -55.7% | -62.8% |
NGM Biopharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $148.64 M(-42.7%) | $148.64 M(-12.5%) |
| Sept 2023 | - | $169.81 M(-11.6%) |
| June 2023 | - | $192.12 M(-13.0%) |
| Mar 2023 | - | $220.93 M(-14.9%) |
| Dec 2022 | $259.56 M(-22.7%) | $259.56 M(-9.2%) |
| Sept 2022 | - | $285.89 M(-2.1%) |
| June 2022 | - | $292.08 M(-6.1%) |
| Mar 2022 | - | $311.14 M(-7.3%) |
| Dec 2021 | $335.65 M(+19.9%) | $335.65 M(-5.2%) |
| Sept 2021 | - | $354.04 M(-5.1%) |
| June 2021 | - | $373.07 M(-6.6%) |
| Mar 2021 | - | $399.58 M(+42.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $280.04 M(-15.3%) | $280.04 M(+1.2%) |
| Sept 2020 | - | $276.70 M(-8.1%) |
| June 2020 | - | $301.16 M(-5.6%) |
| Mar 2020 | - | $318.97 M(-3.6%) |
| Dec 2019 | $330.72 M(-405.7%) | $330.72 M(-2.5%) |
| Sept 2019 | - | $339.19 M(-2.0%) |
| June 2019 | - | $346.13 M(-390.4%) |
| Mar 2019 | - | -$119.18 M(+10.2%) |
| Dec 2018 | -$108.20 M(-10.6%) | -$108.20 M(-12.4%) |
| June 2018 | - | -$123.45 M(+2.0%) |
| Dec 2017 | -$120.98 M(+5.1%) | -$120.98 M |
| Dec 2016 | -$115.06 M | - |
FAQ
- What is NGM Biopharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual shareholders equity year-on-year change?
- What is NGM Biopharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly shareholders equity year-on-year change?
What is NGM Biopharmaceuticals annual stockholders equity?
The current annual shareholders equity of NGM is $148.64 M
What is the all time high annual shareholders equity for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual stockholders equity is $335.65 M
What is NGM Biopharmaceuticals annual shareholders equity year-on-year change?
Over the past year, NGM annual stockholders equity has changed by -$110.92 M (-42.73%)
What is NGM Biopharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of NGM is $148.64 M
What is the all time high quarterly shareholders equity for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly stockholders equity is $399.58 M
What is NGM Biopharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, NGM quarterly stockholders equity has changed by -$72.30 M (-32.72%)